Insitro Company
At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.
Investors
Connections from
Funding Status:
Late Stage Venture
Industry:
Medical BioTech
Headquarters:
South San Francisco, California, United States
Total Funding:
743000000
Last Funding Date:
2021-03-15
Last Funding Type:
Series C
Employee Number:
101-250
Investors Number:
20
Founded Date:
2018-01-01